Eural Precursor Cell Expressed, Developmentally Down-Regulated 4-Like (NEDD4L) antibody

Details for Product No. ABIN361557
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms NEDD4-2, NEDD4.2, RSP5, hNEDD4-2, nedd4, nedd4-2, NEDD4, Nedd4-2, 1300012C07Rik, Nedd4b
Reactivity
Human
(29), (24), (17), (13), (13), (12), (1)
Host
Mouse
(32), (3)
Clonality
Polyclonal
Conjugate
Un-conjugated
(2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Application
Western Blotting (WB)
(25), (11), (10), (6), (5), (3), (3), (1), (1)
Pubmed 3 references available
Quantity 50 μg
Shipping to United States (Change)
Availability Will be delivered in 9 to 11 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN361557
627.13 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Recombinant protein of full length Human NEDD4L
Purification Protein A purified
Alternative Name NEDD4L
Gene ID 23327
Research Area Enzymes
Application Notes WB: 1ug/ml.
Restrictions For Research Use only
Concentration 0.46 mg/ml
Buffer PBS, pH 7.2
Storage -20 °C
General Chen, Ross, Wang et al.: "NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene." in: European journal of human genetics : EJHG, Vol. 9, Issue 12, pp. 922-30, 2002 (PubMed).

Malbert-Colas, Nicolas, Galand et al.: "Identification of new partners of the epithelial sodium channel alpha subunit." in: Comptes rendus biologies, Vol. 326, Issue 7, pp. 615-24, 2003 (PubMed).

Qi, Grenier, Fournier et al.: "Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells." in: Molecular and cellular endocrinology, Vol. 210, Issue 1-2, pp. 51-62, 2003 (PubMed).

Validation Images
Did you look for something else?
back to top